David Michael Miller
Medical Oncologist and Dermatologist
Massachusetts General Hospital
David Michael Miller, MD, PhD, FAAD is a Board-Certified Dermatologist, Internist and Medical Oncologist at Massachusetts General Hospital and investigator in the Massachusetts General Hospital Cancer Center. The Miller Lab’s long-term goal is to identify and develop novel therapeutics for advanced skin cancer and to understand the mechanism of response and resistance to those therapies.
Dr. Miller graduated with Honors from Boston College where he earned a BA in Political Science. He received his medical (MD) and PhD degree in Biomedical Sciences from the University of Massachusetts. While at UMass, Dr. Miller received the American Diabetes Association Physician-Scientist Training Award, a Fuller Foundation grant, and he was inducted into the Alpha Omega Honor Society.
He then completed a Dermatology residency at Columbia University Medical Center, followed by a residency in Internal Medicine at Brigham and Women’s Hospital. Following both residencies, Dr. Miller completed fellowship training in Hematology/Oncology at Beth Israel Deaconess Medical Center and in the Oncology Center of Excellence at the Food and Drug Administration.
Dr. Miller is one of the very few clinicians in the country who is board certified in Internal Medicine, Dermatology and Medical Oncology. He currently practices both Dermatology and Medical Oncology in the Massachusetts General Hospital Cancer Center and at Massachusetts Eye and Ear Infirmary, where he is the Director of the Center for Merkel Cell Carcinoma. Dr. Miller also co-directs multidiscliplinary clinics in advanced skin cancer at both MGH and MEEI.
Dr. Miller belongs to several professional organizations, including the American Academy of Dermatology, Medical Dermatology Society, and the American Society of Clinical Oncology. He has numerous peer-reviewed publications and he has presented his work at the Society for Investigative Dermatology, New York Academy of Medicine, the American Academy of Dermatology, and the U.S. FDA. He is also a reviewer for the British Journal of Dermatology, Journal of Investigative Dermatology, JAEDV, and Clinical Cancer Research.
Due to his expertise in Merkel Cell Carcinoma and Squamous Cell Carcinoma, Dr. Miller has also served on advisory boards to several pharmaceutical companies, inlcuding Pfizer, Merck, Regeneron and Sanofi Genzyme.
The Miller Lab’s research portfolio consists of clinical and translational projects in Merkel Cell carcinoma, cutaneous Squamous Cell Carcinoma and Melanoma. Dr. Miller has received support for his research from the NIH in the form of a loan repayment award, a Research Grant from the American Skin Association, the Paul Carbone, MD fellowship award from ECOG-ACRIN, and the Mentoring Award in Oncology, Advanced Analytics and Regulatory Science from Project Data Sphere.
Board Certifications
Dermatology, American Board of Dermatology
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Dr. Miller’s Link to the MGH Cancer Center
Interests
- Clinical And Translational Research
- Advanced Skin Cancer
- Data Science
- R
Education
-
Fellowship in Hematology/Oncology, 2015
Beth Isreal Deaconess Medical Center
-
Oncology Center for Excellence Fellowship, 2018
Food and Drug Administration
-
Residency in Internal Medicine, 2015
Brigham and Women's Hospital
-
Residency in Dermatology, 2014
Columbia University Medical Center
-
Doctorate of Medicine, 2010
University of Massachusetts Medical School
-
PhD in Biomedical Sciences, 2010
University of Massachusetts Medical School
-
BA in Political Science, 2000
Boston College